Towards a population-based threshold of protection for COVID-19 vaccines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards a population-based threshold of protection for COVID-19 vaccines
Authors
Keywords
COVID-19, SARS-CoV-2, COVID vaccines, Correlates of protection
Journal
VACCINE
Volume 40, Issue 2, Pages 306-315
Publisher
Elsevier BV
Online
2021-12-16
DOI
10.1016/j.vaccine.2021.12.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries
- (2021) David Goldblatt et al. JOURNAL OF HOSPITAL INFECTION
- SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
- (2021) Xiaoying Shen et al. Cell Host & Microbe
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- WHO International Standard for anti-SARS-CoV-2 immunoglobulin
- (2021) Paul A Kristiansen et al. LANCET
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
- (2021) Tamara Pilishvili et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- Covid-19: Longer interval between Pfizer doses results in higher antibody levels, research finds
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
- (2020) James Brett Case et al. Cell Host & Microbe
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2
- (2020) Marina Johnson et al. JOURNAL OF CLINICAL VIROLOGY
- SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response
- (2020) Adi V Gundlapalli et al. Open Forum Infectious Diseases
- Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles
- (2019) Tom Woudenberg et al. Vaccines
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search